What are Rigel Pharmaceuticals's profit margins?

Rigel Pharmaceuticals (RIGL) runs a 93.4% gross margin and a 41.6% operating margin, with a 121.5% net margin.

Where do Rigel Pharmaceuticals's ratios come from?

Every ratio is computed from Rigel Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Rigel Pharmaceuticals RIGL Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	93.4%+3.7pp	93.3%+3.7pp	93.1%+3.7pp	91.5%-0.9pp	89.6%-3.6pp
Operating margin	41.6%+19.9pp	42.6%+29.1pp	42.2%+37.4pp	39%+47.5pp	21.6%+35.5pp
Net margin	121.5%+103pp	124.7%+115pp	40.2%+38.2pp	36.5%+48.0pp	18.3%+35.4pp
EBITDA margin	42.4%+19.5pp	43.5%+28.7pp	43%+37.0pp	39.9%+47.1pp	22.8%+35.6pp
Returns
Return on equity	174.1%—	185.9%—	——	——	——
Return on assets	107%+82.5pp	108.3%+95.9pp	59.3%+56.9pp	58.4%+70.6pp	24.6%+41.0pp
Efficiency
Asset turnover	0.9×-0.5×	0.9×-0.4×	1.5×+0.2×	1.6×+0.5×	1.3×+0.4×
Inventory turnover	2.4×-1.3×	2.2×-1.0×	2.2×-0.9×	2.5×+1.4×	3.7×+2.8×
Liquidity
Current ratio	2.6×+0.4×	2.4×+0.3×	2.3×+0.3×	2×+0.4×	2.2×+0.9×
Quick ratio	2.5×+0.4×	2.3×+0.3×	2.1×+0.3×	1.9×+0.4×	2.1×+1.0×
Cash ratio	0.3×-0.4×	0.4×-0.5×	0.5×-0.4×	0.6×0.0×	0.7×+0.3×
Leverage
Debt-to-equity	0.2×+0.1×	0.2×+0.1×	0×—	0×—	0.1×—
Debt-to-assets	0.1×+0.1×	0.2×+0.2×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	0.3×+1.3×	0.3×+2.5×	-0.4×+5.0×	-0.5×—	-1×—
Interest coverage	18.1×+12.5×	17.1×+14.1×	15.7×+14.7×	13.5×+14.9×	5.6×+7.8×
Per Share
Book value per share	$20.31+1,888%	$20.78+11,078%	$6.14+840%	$4.51+365%	$1.02+157%
Valuation
Market capitalization	$684.39M+102%	$777.42M+162%	$508.16M+78.5%	$334.21M+132%	$321.35M+23.8%
Enterprise value	$728.29M+148%	$820.29M+242%	$460.78M+97.4%	$282.04M+159%	$276.89M+17.9%
Price / earnings	1.9×-7.2×	2.1×-14.8×	4.5×-86.1×	3.4×—	8.6×—
Price / sales	2.3×+0.6×	2.6×+1.0×	1.8×0.0×	1.2×+0.1×	1.6×-0.6×
Price / book	1.7×-16.5×	2×-88.1×	4.3×—	4.1×—	17.3×—
EV / EBITDA	5.7×-0.6×	6.4×-2.7×	3.8×-20.9×	2.6×—	6×—
EV / sales	2.4×+1.0×	2.8×+1.4×	1.6×+0.2×	1.1×+0.2×	1.4×-0.6×
Earnings yield	53.2%+42.2pp	47.2%+41.3pp	22.3%+21.2pp	29.3%+39.6pp	11.6%+19.5pp
PEG ratio	0×—	0×—	0×—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Rigel Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Rigel Pharmaceuticals's profit margins?: Rigel Pharmaceuticals (RIGL) runs a 93.4% gross margin and a 41.6% operating margin, with a 121.5% net margin.
Where do Rigel Pharmaceuticals's ratios come from?: Every ratio is computed from Rigel Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.